The European list of key medicines for medical education: a modified Delphi study
Donker, Erik M. ; Spitaleri Timpone, Pietro... [et al.] ; Network of Teachers in Pharmacotherapy ; Bernal, María Luisa (Universidad de Zaragoza) ; Pérez Calvo, Juan Ignacio (Universidad de Zaragoza) ; Avedillo Salas, Ana (Universidad de Zaragoza)
Resumen: Rational prescribing is essential for the quality of health care. However, many final-year medical students and junior doctors lack prescribing competence to perform this task. The availability of a list of medicines that a junior doctor working in Europe should be able to independently prescribe safely and effectively without supervision could support and harmonize teaching and training in clinical pharmacology and therapeutics (CPT) in Europe. Therefore, our aim was to achieve consensus on such a list of medicines that are widely accessible in Europe. For this, we used a modified Delphi study method consisting of three parts. In part one, we created an initial list based on a literature search. In part two, a group of 64 coordinators in CPT education, selected via the Network of Teachers in Pharmacotherapy of the European Association for Clinical Pharmacology and Therapeutics, evaluated the accessibility of each medicine in his or her country, and provided a diverse group of experts willing to participate in the Delphi part. In part three, 463 experts from 24 European countries were invited to participate in a 2-round Delphi study. In total, 187 experts (40%) from 24 countries completed both rounds and evaluated 416 medicines, 98 of which were included in the final list. The top three Anatomical Therapeutic Chemical code groups were (1) cardiovascular system (n = 23), (2) anti-infective (n = 21), and (3) musculoskeletal system (n = 11). This European List of Key Medicines for Medical Education could be a starting point for country-specific lists and could be used for the training and assessment of CPT.
Idioma: Inglés
DOI: 10.1002/cpt.3132
Año: 2023
Publicado en: CLINICAL PHARMACOLOGY & THERAPEUTICS 115, 3 (2023), 515-524
ISSN: 0009-9236
Factor impacto JCR: 6.3 (2023)
Categ. JCR: PHARMACOLOGY & PHARMACY rank: 25 / 354 = 0.071 (2023) - Q1 - T1
Factor impacto CITESCORE: 12.7 - Pharmacology (medical) (Q1) - Pharmacology (Q1)
Factor impacto SCIMAGO: 1.988 - Pharmacology (medical) (Q1) - Pharmacology (Q1)
Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
Área (Departamento): Área Farmacología (Dpto. Farmac.Fisiol.y Med.L.F.)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes.
Exportado de SIDERAL (2026-01-13-22:06:47)
Visitas y descargas
Idioma: Inglés
DOI: 10.1002/cpt.3132
Año: 2023
Publicado en: CLINICAL PHARMACOLOGY & THERAPEUTICS 115, 3 (2023), 515-524
ISSN: 0009-9236
Factor impacto JCR: 6.3 (2023)
Categ. JCR: PHARMACOLOGY & PHARMACY rank: 25 / 354 = 0.071 (2023) - Q1 - T1
Factor impacto CITESCORE: 12.7 - Pharmacology (medical) (Q1) - Pharmacology (Q1)
Factor impacto SCIMAGO: 1.988 - Pharmacology (medical) (Q1) - Pharmacology (Q1)
Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
Área (Departamento): Área Farmacología (Dpto. Farmac.Fisiol.y Med.L.F.)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. Exportado de SIDERAL (2026-01-13-22:06:47)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Farmacología
Articles > Artículos por área > Medicina
Record created 2026-01-13, last modified 2026-01-13